Urania Therapeutics
FranceEntry
2019
Hold
7yr
Status
Active
Who owns Urania Therapeutics?
Urania Therapeutics is a French Biotech company, currently owned by Capital Grand Est since 2020 and AdBio Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
AdBio PartnersActive
2019 · present(7yr) · AFB Seed-Fund · 2017 · VC
Capital Grand EstActive
2020 · present(6yr) · Cap Innov'Est 1 · 2014 · VC
More from AFB Seed-Fund
Other portfolio companies in the same fund.
Spain
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Urania Therapeutics?
Urania Therapeutics is currently owned by Capital Grand Est and AdBio Partners, through AFB Seed-Fund, since 2020.
When did Capital Grand Est and 1 other acquire Urania Therapeutics?
Capital Grand Est and 1 other acquired Urania Therapeutics in 2020.
Who has owned Urania Therapeutics over time?
Urania Therapeutics has been through 2 private-equity ownership periods: AdBio Partners · via AFB Seed-Fund · since 2019; Capital Grand Est · via Cap Innov'Est 1 · since 2020.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue